An AI scribe fits an Indian oncology OPD if it can keep up with a long, longitudinal narrative, a staging discussion, a chemo cycle note, a toxicity review, spoken across Hindi and English, and hand it back as a clean English draft. It does not stage the cancer, calculate a dose, or remember last cycle. You dictate all of that. What it removes is the writing you never finish on a day-care day that runs to 7pm.
Key takeaways
- The scribe drafts what you dictate. Say the regimen, cycle, and doses and the note reflects them. It does not compute BSA or verify the protocol.
- It captures Hindi, English, and the mid-sentence mix; the note always comes back in clean clinical English.
- It has no memory of prior visits. Cycle number, prior lines, and response trend must be spoken to appear.
- ICD-10 suggestions like C50.911 or C34.90 appear next to the draft. You confirm them. It does not stage or assign TNM.
- Visit audio is processed in memory and discarded at draft; nothing is stored, in line with DPDP Act 2023 expectations. This describes live consultation audio; uploaded recordings use a separate retention mode with explicit consent.
Key facts
- From end of visit to a drafted note
- ~2min
- Entry plan on annual billing, ex-GST
- ₹1,599/clinician/mo
- processed in memory and discarded at note draft; uploads use a separate explicit-consent retention mode
- nolive audio stored
Pricing is ex-GST; add 18% GST for the all-in figure.
Why oncology notes are the hardest to write on a busy day
An oncology consult is rarely one thing. A single visit can carry an interval history since the last cycle, a symptom and toxicity review, a performance-status note, an imaging or pathology summary the patient brought, a decision on whether cycle four goes ahead, a dose adjustment, and a plan that reaches to the next scan. Each piece is its own paragraph of dictation. Stack that against a day-care unit clearing thirty-plus chemo patients and a medical oncology OPD running behind by mid-morning, and the note is what gives.
The longitudinal story is what makes oncology different. In a one-off consult a thin note is survivable. In cancer care the record is the treatment history: which line, which cycle, what the last response was, what toxicity showed up and how you managed it. Six months on, that trail is the clinical decision. A one-line “continue chemo” entry loses exactly the information the next visit depends on.
The medico-legal weight is heavier here too. The operative 2002 medical ethics code requires three-year retention for indoor records and production of requested records within 72 hours. In oncology, where consent for a regimen, a discussion of prognosis, and a documented toxicity are all part of the standard of care, the note is not paperwork. It is evidence that the conversation happened. Thin notes in a specialty this consequential are an exposure, not just an inconvenience.
Better clinic software does not solve this. A faster billing screen does not write the tumour-board summary. The constraint is time at the point of care, and there is never enough of it on a full day-care list.
How the scribe fits an oncology visit
You start a session when the patient sits down and run the consult the way you always do. As you take the interval history and review toxicity, you speak your findings the way you would dictate them: “cycle three of six, FOLFOX, no significant neuropathy, grade one nausea managed with ondansetron, ECOG one, weight stable.” The scribe captures it in English, in Hindi, or in the mix of both that a real consult actually uses.
When the patient hands you a recent scan report and you read the relevant line into the record, dictate it. “CT chest shows partial response, target lesions down about thirty percent.” That is your read. The scribe writes it as you said it. It is not looking at the images, measuring anything, or deciding the response category. You did that. The scribe is a stenographer for the note, not a reader of the study.
Here is the canonical version of that flow. AI Scribe by Patient Square is an ambient AI medical scribe that listens during the visit and hands back a structured SOAP note, ICD-10 suggestions, and a prescription draft, ready to review and sign about two minutes after the visit. In oncology terms, after the patient leaves you stop the session, and about two minutes later there is a draft: interval history, toxicity review, exam, your imaging and pathology summaries, assessment, and the plan for this cycle. You read it, correct anything wrong, and sign.
The AI Medical Scribe is the ambient module inside Practice Copilot, so it runs alongside whatever oncology records system you already use. There is no HL7, FHIR, or EHR integration involved. You copy or export the finished note into your chart. Three India-specific points matter: the note always comes back in clean clinical English no matter how you dictated it, the audio is never stored, and the regimen output is a draft you review, never something the tool transmits to a pharmacy. Our multi-specialty scribe guide covers how the same tool adapts across departments if oncology shares a clinic with other specialties. This describes live consultation audio; uploaded recordings use a separate retention mode with explicit consent.
What you say versus what the scribe drafts
The honest way to explain the ceiling is element by element. For every part of an oncology note, you dictate the clinical content and the scribe drafts the text. Nothing in the right column is a calculation, an interpretation, or a check the tool performs on its own.
| Note element | What you say | What the scribe drafts |
|---|---|---|
| Staging | ”Clinical stage cT3 N1 M0, confirmed on biopsy” | The stage in your words, verbatim, into the assessment |
| Chemo regimen | ”Cycle 4 of 6, FOLFOX, oxaliplatin and 5-FU per protocol” | A regimen draft with the cycle and agents you dictated |
| Dose | ”Reduced 5-FU to 80 percent for last cycle’s mucositis” | The dose statement as spoken, not a recalculated figure |
| Toxicity | ”Grade 2 peripheral neuropathy, oxaliplatin held this cycle” | The toxicity and your management, in the note |
| Response | ”Partial response on latest CT, target lesions smaller” | Your stated response read, not a derived category |
| Supportive care | ”Started G-CSF, antiemetics stepped up, dietician referral” | The supportive-care plan you dictated |
The scribe drafts the left column into clean English. It does not compute doses, calculate body surface area, screen for interactions, or verify the protocol. Chemo dosing and protocol verification stay entirely yours.
That distinction is the whole point. If you want the scribe to work out a carboplatin AUC dose or flag an interaction, it will not, and it should not pretend to. Dose and safety are the oncologist’s decision. The scribe’s job is to stop you retyping the note at 8pm, not to make clinical calls.
ICD-10 suggestions you confirm, never staging
Alongside the draft, the scribe offers ICD-10 code suggestions pulled from what you dictated. They sit next to the note as suggestions, not entries. You confirm, change, or reject each one, and nothing is auto-coded or posted as a charge.
| What you dictate | ICD-10 suggestion (for you to confirm) |
|---|---|
| Breast cancer, female breast, unspecified site | C50.911 |
| Lung cancer, unspecified part of bronchus or lung | C34.90 |
| Colon cancer, unspecified site | C18.9 |
| Non-Hodgkin lymphoma, unspecified | C85.90 |
| Chronic myeloid leukaemia, BCR/ABL-positive | C92.11 |
Suggestions are a starting point for your judgement, not a coding action. The scribe does not stage cancers, assign TNM, or select a code on its own. You confirm every one.
Read that carefully, because it is a common misunderstanding. An ICD-10 code is a diagnosis label, not a stage. The scribe suggesting C50.911 tells you it heard “breast cancer,” not that it worked out the T, N, and M. Staging is a clinical judgement you make from pathology, imaging, and exam, and you dictate it. The scribe writes it down. It does not derive it.
No memory, so dictate the trend every time
This is the limit that catches oncologists off guard, so we will be blunt about it. The scribe has no memory of prior visits. It does not know this is cycle four, that the patient was on FOLFIRI first line, or that the last scan showed progression. If you do not say those things in this consult, they will not be in this note.
In most specialties that matters less. In oncology it shapes how you dictate. The value of the record is the trend, so the trend has to be spoken. “Second line since March, cycle four of FOLFOX, previous FOLFIRI stopped for progression, last CT showed partial response” is the kind of sentence that makes the note useful six months later. Say it, and the scribe drafts it. Skip it, and you get a snapshot with no history.
We think this is the honest framing rather than overselling a “longitudinal AI.” The scribe is a fast, accurate note-taker for the visit in front of it. It is not a patient timeline that remembers your panel. If you dictate the story each time, it captures the story each time. Our medico-legal documentation guide covers why that spoken trail matters when a record is later reviewed.
Security, DPDP, and the medico-legal record
Oncology consults are about as sensitive as clinical conversations get: a diagnosis, a prognosis, family history, and consent for treatment, often with relatives in the room. The data posture has to match that.
The audio is processed in memory and discarded once the note drafts. There is no recording sitting on a server afterward, which is the cleaner stance under the Digital Personal Data Protection Act, 2023. Notes are encrypted in transit and at rest with TLS 1.2+ and AES-256. On certifications, we will be exact rather than aspirational: a SOC 2 audit is underway and not yet certified, and the product is DPDP-aligned in its handling, not DPDP-certified. We do not claim a certificate we do not hold. This describes live consultation audio; uploaded recordings use a separate retention mode with explicit consent.
On ABDM, the same honesty applies, because Indian oncology practices are right to ask. Live ABDM record linking is on our roadmap, not shipped, and we are not ABDM-certified. If you need to link a cancer patient’s records to their ABHA number today, that is a real requirement and the honest pointer is a platform that already does it. eka.care, for example, offers live ABHA linkage now, and if that is your dealbreaker, they are the better fit for that specific need. We would rather tell you that than pretend a roadmap item is a shipped feature. Our Hindi and Indian-languages guide covers the language handling if bilingual capture is the higher priority for your clinic.
And the note stays a draft until you sign it. Legal responsibility for the chart stays with the signing oncologist, exactly as it should in a specialty where the documentation is part of the standard of care.
Where the fit stands or falls
Being straight about when this is the wrong tool matters more than a feature list. The scribe fits a busy day-care or medical oncology OPD where the real problem is that notes pile up and get finished at night. It drafts the long narrative, captures the bilingual consult, and hands back clean English about two minutes after the visit. For a high-volume list, getting a minute or two back per note and finishing before you leave is where it earns its place. Our scribe cost math for an Indian solo doctor has a framework if you want to run your own numbers.
It is the wrong tool if you expected clinical support. It does not compute chemo doses, calculate BSA, screen for drug interactions, verify a protocol, stage the cancer, or remember prior cycles. Those are yours, and they should be. If your bottleneck is dosing safety or a longitudinal timeline rather than the writing itself, an ambient scribe does not solve that problem, and you should not buy it expecting it to.
For the honest verdict: this is a documentation aid, not a clinical-decision tool. It fits oncologists who dictate their reads and drown in after-hours charting. It does not fit anyone hoping the software will make the treatment call. The best AI scribe for India roundup compares the India-facing options if you are shortlisting more than one, and our NMC record-keeping explainer covers what the regulations actually expect from a note.
The way to test it is on your own day-care list during the 7-day free trial after the workspace is ready. Dictate a real cycle note with a dose adjustment and a toxicity, in your usual Hindi-English mix, and check whether the draft comes back in oncology English or flattens it. Then run it on your heaviest half-day and see whether the notes stay clean and separate. That is the only accuracy figure worth trusting.
If you want to see draft quality against your own consults before committing anything, compare the options and bring a typical complex case, or check what each plan includes on the pricing page first. Entry pricing is ₹1,599 per clinician per month on annual billing, ex-GST; Copilot is ₹2,399 and Autopilot ₹3,999. Add 18% GST and the entry invoice is about ₹1,887 a month. For an oncology unit clearing a full list, that is a small test against a real problem.